MeCure Industries Plc, recently listed on the Nigerian Exchange Limited (NGX), has announced the official implementation of its Track & Trace solution, a programme with a cutting edge technology ensuring product safety for its customers.
Given the current pharmaceutical governance landscape, the industry faces a dual imperatives: ensuring the accessibility of life-saving medications while mitigating potential threats such as falsification. The Track & Trace solution emerges as a pivotal solution, playing a critical role in preventing the infiltration of counterfeit drugs into the healthcare supply chain.
MeCure, in collaboration with ACG Inspection, a globally recognised Track & Trace Solution provider, has demonstrated unwavering commitment to the regulator by elevating industry standards on patient safety through offering authentication of each product with just a click of any smartphone.
Eighteen brands within the MeCure portfolio are currently Track & Trace enabled, and all of its 50+ brands will be traceable by the end of first quarter of 2024.
